AU-5.1.5
Past version: Effective up to 30 Jun 2007
To view other versions open the versions tab on the right
Unless otherwise directed by the BMA, the following documents must be provided as Part of Phase 1 in support of a license application:
(a) a duly completed Form 2 (Application for Authorisation of Controller) for each controller of the proposed licensee;
(b) a duly completed Form 3 (Application for Approved Person status), for each proposed Director of the proposed licensee;
(c) a comprehensive business plan for the application, addressing the matters described in AU-5.1.6;
(d) where the applicant is already incorporated, a copy of the applicant's commercial registration (or equivalent in the case of companies incorporated in an overseas jurisdiction);
(e) where the applicant is already incorporated, a certified copy of a Board resolution of the applicant, confirming its decision to seek a BMA investment firm license;
(f) details of the proposed licensee's close links as required under Chapter GR-6;
(g) in the case of applicants that are part of a regulated group, a letter of non-objection to the proposed license application from the applicant's home supervisor , together with confirmation that the group is in good regulatory standing and is in compliance with applicable supervisory requirements, including those relating to capital and solvency requirements;
(h) in the case of branch applicants, a letter of non-objection to the proposed license application from the applicant's home supervisor, together with confirmation that the applicant is in good regulatory standing and is in compliance with applicable supervisory requirements, including those relating to capital and solvency requirements;
(i) in the case of branch applicants, copies of the audited financial statements of the applicant (head office) for the three years immediately prior to the date of application; and
(j) in the case of other applicants, copies of the audited financial statements of the applicant's major shareholder and/or group (as directed by the BMA), for the three years immediately prior to the date of application.